pain relief back and body
- Product NDC
- 11822-4130
- 11-digit product format
- 118224130
- Labeler code
- 11822
- Product ID
- 11822-4130_00de4cde-f606-4ad4-af41-409e48dee60d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin, Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Rite Aid Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2004-04-12
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 500; 32.5 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 11822-4130 | 11822-4130-5 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- pain relief back and body
- Brand name suffix
- EXTRA STRENGTH
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 500 mg/1 |
| CAFFEINE | 32.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 702316 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a71392c8-3f5b-4d00-baba-a4055ed68bc1 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-4130-2 | pain relief back and bodyEXTRA STRENGTH | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 9 | |
| 11822-4130-2 | pain relief back and bodyEXTRA STRENGTH | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 9 | |
| 11822-4130-5 | pain relief back and bodyEXTRA STRENGTH | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 9 | |
| 11822-4130-5 | pain relief back and bodyEXTRA STRENGTH | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-4130 | PAIN RELIEF BACK AND BODY EXTRA STRENGTH (ASPIRIN, CAFFEINE) TABLET, FILM COATED [RITE AID CORPORATION] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250110_a71392c8-3f5b-4d00-baba-a4055ed68bc1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Westminster Pharmaceuticals, LLC | ace5ebac-ec11-4c26-b1e3-954b450ee671 | 2021-05-04 | Warnings | M013 |
| Aspirin Enteric Coated | ASPIRIN 81 MG | Allegiant Health | 8cacf02c-9925-40d4-92bc-78788aa0681a | 2020-11-11 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN 500 MG | Allegiant Health | 8e60b78e-ef3c-4d44-b8d4-37cb8608a5c7 | 2020-03-13 | Warnings | M013 |
| Acetaminophen 500mg ES | ACETAMINOPHEN 500MG | Allegiant Health | 91acc132-01b6-467b-9af5-70f4dc93e087 | 2019-01-08 | Warnings | M013 |
| Acetaminophen 325mg RS | ACETAMINOPHEN 325MG | Allegiant Health | 61c6d281-e59b-4277-bbce-f71c12c2a56d | 2019-01-07 | Warnings | M013 |
| Cold Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Allegiant Health | 9a4c0c43-a71a-4e22-a3d5-9eb9622689a2 | 2019-01-02 | Warnings | M013 |
| Pain Relief PM Extra Strength | ACETAMINOPHEN 500 MG AND DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | 423a8445-964c-4cdb-889a-f391ca5253e7 | 2018-12-31 | Warnings | M013 |
| Cold Multi-Symptom Night-time | ACETAMINOPHEN,CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR AND PHENYLEPHRINE HCI | Allegiant Health | 3f020cf2-6011-4216-9b39-0b3dc5f0749c | 2018-12-26 | Warnings | M013 |
| Aspirin Chewable | ASPIRIN 81 MG | Allegiant Health | 92b8637b-03a9-461f-b2f6-6eddaa214953 | 2018-12-21 | Warnings | M013 |
| Sinus Headache PEMaximum Strength Non-Drowsy Maximum Strength Non-Drowsy | ACETAMINOPHEN AND PHENYLEPHRINE HCL | Allegiant Health | b04b96e0-d99b-48d1-b8b8-e2fdd8dd3f5f | 2018-12-21 | Warnings | M013 |
| Clear Choice Regular Strength Pain Reliever | ACETAMINOPHEN | Athlete's Needs, Inc. | d0d9fda5-5eba-4d51-b505-e93a2ae0bdd7 | 2018-12-11 | Warnings | M013 |
| ASPIRIN Enteric Coated | ASPIRIN 81 MG | Allegiant Health | 5910a882-eb40-440f-8a30-c21fbce9050e | 2018-11-07 | Warnings | M013 |
| Aspirin | ASPIRIN 325 MG | Allegiant Health | 88b54062-8b3d-4024-a957-62b3255184b9 | 2018-11-07 | Warnings | M013 |
| Aspirin Enteric Coated | ASPIRIN 81 MG | Allegiant Health | 3ca60fa3-0a0c-4b3e-a0a2-da527ccf4fe5 | 2018-11-07 | Warnings | M013 |
| Tension Headache Relief | TENSION HEADACHE RELIEF | Allegiant Health | b431a1a3-39c4-4d6c-afdc-c8b017ad89da | 2017-11-16 | Warnings | M013 |
| SED-MAX | ACETAMINOPHEN 500 MG WITH CAFFEINE 65MG | Command Brands, LLC | 4920a0e9-6f88-4df0-8657-77c95a3b9617 | 2017-01-19 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702316 | aspirin 500 MG / caffeine 32.5 MG Oral Tablet | PSN | a71392c8-3f5b-4d00-baba-a4055ed68bc1 | 9 |
| 702316 | aspirin 500 MG / caffeine 32.5 MG Oral Tablet | SCD | a71392c8-3f5b-4d00-baba-a4055ed68bc1 | 9 |
| 702316 | ASA 500 MG / Caffeine 32.5 MG Oral Tablet | SY | a71392c8-3f5b-4d00-baba-a4055ed68bc1 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 11822-4130-2 | 11822413002 | 1 BOTTLE in 1 CARTON (11822-4130-2) / 100 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2004-04-12 | 2022-10-01 | No | No | Current |
| 11822-4130-5 | 11822413005 | 50 in 1 BOTTLE | Historical |